Dermapharm Holding SE
General ticker "DMPHF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.1B (TTM average)
Dermapharm Holding SE follows the US Stock Market performance with the rate: 5.6%.
Estimated limits based on current volatility of 0.3%: low 39.43$, high 39.66$
Factors to consider:
- Earnings expected soon, date: 2026-05-13 bmo
- Company pays dividends (irregularly): last record date 2025-06-30, amount 1.06$ (Y2.68%)
Short-term DMPHF quotes
Long-term DMPHF plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €1,180.77MM | €1,164.54MM |
| Operating Expenses | €963.83MM | €942.88MM |
| Operating Income | €216.93MM | €221.66MM |
| Non-Operating Income | €-44.93MM | €-38.22MM |
| Interest Expense | €58.41MM | €52.64MM |
| R&D Expense | €11.54MM | €11.17MM |
| Income(Loss) | €172.00MM | €183.44MM |
| Taxes | €60.27MM | €52.14MM |
| Profit(Loss)* | €113.79MM | €132.36MM |
| Stockholders Equity | €604.42MM | €694.12MM |
| Inventory | €339.86MM | €328.59MM |
| Assets | €2,080.02MM | €2,204.00MM |
| Operating Cash Flow | €201.38MM | €181.44MM |
| Capital expenditure | €38.24MM | €42.10MM |
| Investing Cash Flow | €-29.61MM | €-109.99MM |
| Financing Cash Flow | €-209.17MM | €13.32MM |
| Earnings Per Share** | €2.11 | €2.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.